The maintained full-year guidance provides a floor for expectations, but the constant currency revenue decline and margin compression indicate the turnaround is still early. Watch for Q2 results to see if the restructuring plan gains traction; any downward guidance revision would be severe.
Price Chart
Executive Summary
Dentsply Sirona reported Q1 2026 adjusted EPS of $0.27, roughly in line with the $0.28 consensus (a slight miss), while revenue of $880M was flat YoY but constant currency sales fell 6.7%. GAAP results worsened to a net loss of $10M vs income of $20M last year, and adjusted EBITDA dropped 23% YoY. The company reiterated its full-year 2026 guidance, which tempers the negative read, but underlying trends remain weak with declining margins and ongoing restructuring charges.
Key Financial Metrics
Key Facts
- Adjusted EPS of $0.27 vs $0.28 consensus (miss of ~3.6%)
- Revenue of $880M, +0.1% YoY reported, but constant currency down 6.7%
- GAAP net loss of $10M vs net income of $20M in Q1 2025
- Adjusted EBITDA fell 22.8% to $129M, margin down 430bps to 14.7%
- Full-year 2026 outlook maintained: net sales $3.5B-$3.6B, adjusted EPS $1.40-$1.50
- Restructuring costs of $67M in Q1 2026 (vs $9M in Q1 2025) weighed on results
- Cash flow from operations improved to $40M vs $7M a year ago, but FCF remained negative at ($12M)
Financial Impact
Adjusted EPS miss of ~$0.01 vs consensus, but the YoY decline in adjusted EPS from $0.44 to $0.27 is significant, representing a 39% drop.
Risk Factors
- Continued deterioration in constant currency sales, particularly in Americas and EMEA
- Restructuring execution risk and potential for further impairments
- High debt levels ($2.2B net debt) could pressure cash flows if operating performance doesn't improve
- Competitive pressure in dental equipment and implant solutions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000818479-26-000147 |
| Document: dentsply8kq12026ex992.htm | 0000818479-26-000147 |
| Document: xray-20260505.htm | 0000818479-26-000147 |
| Document: 0000818479-26-000147-index-headers.html | 0000818479-26-000147 |
| Document: 0000818479-26-000147-index.html | 0000818479-26-000147 |
| Document: 0000818479-26-000147.txt | 0000818479-26-000147 |
| 8-K Data (Synthetic) | 0000818479-26-000147 |
Track record
15 reports on XRAY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Bearish 6/10 No price data
- Nov 5, 202611d ago Press Release Bearish 6/10 Entry $9.46 to $9.16 Now $8.95 +5.39% ▲ +3.17% +5.77% vs SPY
- Nov 5, 202611d ago Institutional Cluster Neutral 2/10 Entry $10.09 to $9.24 Now $8.95 −11.30% ▼ −8.42% −11.71% vs SPY
- Oct 20, 202627d ago Press Release Neutral 1/10 Entry $9.08 Now $8.95 −1.43% No price data
- Oct 9, 20265w ago 8-K Neutral 4/10 Entry $8.53 to $8.42 Now $8.95 +4.92% ▼ −1.29% +0.20% vs SPY
- Sep 10, 20269w ago Institutional Cluster Mixed 5/10 Entry $10.50 to $9.38 Now $8.95 −14.76% ▼ −10.71% −10.22% vs SPY
- Jun 16, 202621w ago Insider Cluster Neutral 3/10 Entry $10.03 to $10.52 Now $8.95 −10.77% ▲ +4.89% +5.93% vs SPY
- Jun 15, 202622w ago Insider Cluster Neutral 3/10 Entry $10.45 to $10.20 Now $8.95 −14.35% ▼ −2.39% −0.16% vs SPY
- Jun 11, 202622w ago 8-K Neutral 3/10 Entry $10.14 to $10.03 Now $8.95 −11.74% ▼ −1.08% −1.52% vs SPY
- May 5, 202627w ago 8-K Bearish 6/10 Viewing No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers